Intellectual functioning in alpha‐mannosidosis. Issue 1 (21st September 2019)

• Record Type: Journal Article
• Authors: Cathey, Sara S.; Sarasua, Sara M.; Simensen, Richard; Pietris, Katie; Kimbrell, Gordon; Sillence, David; Wilson, Callum; Horowitz, Lucia
• Is Part Of: JIMD reports. Volume 50:Issue 1(2019)
• Page Start: 44
• Page End: 49
• Publication Date: 2019-09-21
• Subjects: alpha‐mannosidosis -- glycoproteinoses -- intellectual disability -- IQ; Metabolism, Inborn errors of -- Periodicals; Metabolism -- Disorders -- Periodicals; 616.39042
• DOI: 10.1002/jmd2.12073
• Languages: English
• ISSNs: 2192-8304

Abstract

Abstract: Alpha‐mannosidosis is a rare inherited metabolic disorder (OMIM #248500) caused by mutations in the enzyme α‐mannosidase encoded by the gene MAN2B1 . Patients have distinct physical and developmental features, but only limited information regarding standardized cognitive functioning of patients has been published. Here we contribute intellectual ability scores (IQ) on 12 patients with alpha‐mannosidosis (ages 8‐59 years, 10 males, 2 females). In addition, a pooled analysis was performed with data collected from this investigation and 31 cases obtained from the literature, allowing a comprehensive analysis of intellectual functioning in this rare disease. The initial and pooled analyses show that patients with alpha‐mannosidosis have variable degrees of intellectual disability but show decline in IQ with age, particularly during the first decade of life. Patients treated with hematopoietic stem cell transplantation tend to show stabilized cognitive abilities.